Practical Issues for Pharmacists
It is well-known that cancer management presents numerous challenges, challenges that crop up from the beginning of care—at diagnosis.
Health Disparities, Financial Toxicity, Bispecific Antibodies, Clinical Pathways, Practical Issues for Pharmacists
The Hematology/Oncology Pharmacy Association (HOPA) has launched a collaborative network designed to help hematology/oncology pharmacists and other clinicians to more efficiently navigate complex practice challenges.
The conversation around work-life balance in healthcare can sometimes feel like a luxury, or worse, a myth. But in oncology pharmacy, balance isn’t about perfection or strict boundaries; it’s about sustainability.
A coalition of more than 40 health insurers recently announced plans for prior authorization reform.
By Sara Erickson, PharmD, BCACP; Anna Bartoo, PharmD, BCPS; Amy Wallingford, PharmD; Susan Wescott, MBA, RPh; Chelsee Jensen, PharmD, BCPS, P-RCM, RPh
Biosimilars offer a significant opportunity for cost-savings yet present logistical hurdles for optimal implementation. Biosimilar savings nationwide are estimated to be $54 billion from 2017 to 2026, but these savings hinge on industry, regulatory, and policy changes to strengthen competition and sustainability in the biosimilar marketplace.
By Joseph Haroney, PharmD, BCPS; Amanda Kogelman, PharmD, BCOP; Chelsea Palmer, CPhT-Adv, CSPT; Aimee Cloud, PharmD, BCOP; Daniel Kroll, PharmD
Annual US spending on oral cancer drugs has surpassed $947 million and is expected to increase 12% to 15% annually through 2027. In many cases, a significant portion of these funds come directly from patients. The out-of-pocket costs for the top 54 oral chemotherapy agents in 2019 were projected to exceed $10,000 per fill annually for patients enrolled in Medicare Part D plans.
On July 19, 2023, an EF3 tornado touched down in Rocky Mount, NC, badly damaging a Pfizer drug manufacturing facility that is responsible for producing nearly 25% of Pfizer’s sterile injectable medicines used in US hospitals.
By Karen Blum
Early last year, Jerome Wohleb, PharmD, MBA, FASHP, Pharmacy Services Director, Bryan Medical Center, Lincoln, NE, faced a dilemma. A Nebraska Pharmacy Workforce Survey revealed a high level of burnout among pharmacists in the aftermath of the COVID-19 pandemic.
Own-occupation disability insurance is often a pharmacist’s best line of defense when protecting his or her income from a disabling event.
The American Society of Health-System Pharmacists (ASHP) Foundation's Pharmacy Forecast, now in its fourth edition, serves to improve the effectiveness of leaders in hospital and health-system pharmacy practice.